Is NASDAQ:DXCM a Fit for Growth Investing Strategies?

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if DEXCOM INC (NASDAQ:DXCM) is suited for growth investing. Investors should of course do their own research, but we spotted DEXCOM INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Exploring Why NASDAQ:DXCM Holds Promise for Growth Investors.

• The Return on Equity(ROE) of DEXCOM INC is 16.62%, which is a strong number. This indicates the company's ability to generate favorable returns for shareholders and reflects its effective management of resources.
• With a track record of beating EPS estimates in the last 4 quarters, DEXCOM INC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
• With impressive 1-year revenue growth of 21.85%, DEXCOM INC showcases its ability to generate increased sales and revenue. This growth highlights the company's strong customer demand and its effective business strategies.
• The quarter-to-quarter (Q2Q) revenue growth of 26.69% of DEXCOM INC has been strong, reflecting the company's ability to generate consistent sales growth. This growth suggests the company's ability to meet customer needs and drive revenue growth.
• DEXCOM INC has shown positive growth in its operating margin over the past year, indicating improved operational efficiency. This growth highlights the company's ability to effectively manage costs and maximize profitability.
• DEXCOM INC has shown positive growth in its free cash flow (FCF) over the past year, indicating improved cash generation and financial strength. This growth highlights the company's ability to effectively manage its cash flows and generate surplus funds.
• DEXCOM INC has shown positive momentum in its earnings per share (EPS) on a quarter-to-quarter (Q2Q) basis, with a 78.57% increase. This reflects the company's successful execution of its business strategies and its commitment to delivering improved financial results.
• The average next Quarter EPS Estimate by analysts was adjusted by 10.34%, reflecting the evolving market expectations for the company's EPS growth.
• In the most recent financial report, DEXCOM INC reported a 78.57% increase in quarterly earnings compared to the previous quarter. This notable growth indicates positive momentum in the company's financials, suggesting an upward trend
• DEXCOM INC shows accelerating EPS growth: when comparing the current Q2Q growth of 78.57% to the previous year Q2Q growth of 25.84%, we see the growth rate improving.

A complete fundamental analysis of NASDAQ:DXCM

ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.

We assign a fundamental rating of 7 out of 10 to DXCM. DXCM was compared to 202 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent on profitability, but there are some minor concerns on its financial health. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make DXCM a good candidate for growth investing.

Our latest full fundamental report of DXCM contains the most current fundamental analsysis.

Our Lois Navellier screen will find you more ideas suited for growth investing.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.